全球動物用OTC藥的市場機會

The OTC Animal Health Global Market Opportunity

出版商	PJB Publications Ltd.
出版日期	2007年03月	商品編碼	50539
內容資訊	英文
價格	本報告書已不再販售

簡介
相關商品

本報告已在2011年08月03日停止出版。

Examine the various market forces acting within the distribution of veterinary medicines
Identify key drivers and the regulatory environment for different retail channels
Review the leading companies in the OTC market
Analyse the strengths and weaknesses of different strategies used for existing products

Executive Summary:

Traditionally sales of animal health products have been via a small number of different retail channels, limited by the regulatory classification of each specific product. Thus, products classified as being suitable for “over-the-counter” (OTC) sales have been widely available across all outlets (including supermarkets, pet superstores, garden centres, pet shops, pharmacies and veterinary clinics), while those restricted to being only available with a prescription have been limited to distribution through the so-called “ethical” channel of either a vet clinic or a pharmacy.

The different retail outlets represent separate marketing channels, and historically certain companies are predominantly active in particular channels. Reputations are built up over time and once forged these commercial relationships can provide a large degree of inertia within each channel of distribution. Companies are continually seeking new product opportunities. One potential opportunity for increasing sales volume would be to expand the number of pharmaceutical products available on the OTC market. Given the inherent difficulty and expense of developing new compounds, the simplest route is via the reclassification as OTC of pharmaceuticals formerly requiring prescriptions. This would then allow a much greater distribution across the range of retail outlets. For the manufacturer this offers the potential for increased volume and for the distributor, range expansion via new product launches. However, apart from the need to obtain regulatory approval, the switch into the general OTC market may conflict with existing ethical sales and cause manufacturers to have to rethink their relationship with those veterinarians who have previously supported a particular product. Nevertheless, for manufacturers with brands nearing the end of the product lifecycle, wider distribution via the OTC channel represents a potentially valuable method of extending profitable sales and generating revenue for re-investment into new compound development.

CHAPTER 1 INTRODUCTION

1.1 Background
1.2 Managing the Product Life-cycle
1.3 Available OTC distribution channels
1.4 Distribution costs
1.5 Online pharm acies
1.6 OTC products: key market drivers

CHAPTER 2 ANIMAL HEALTH MARKETS

2.1 Global overview
2.2 EUROPE
- 2.2.1 European pet market overview
- 2.2.2 France
- 2.2.3 Germany
- 2.2.4 Spain
- 2.2.5 UK Pet Market Size
- 2.2.6 Other countries
2.3 NORTH AMERICA
- 2.3.1 Canada
- 2.3.2 United States
2.4 SOUTH AMERICA
- 2.4.1 Argentina
- 2.4.2 Brazil
2.5 FAR EAST/ASIA
- 2.5.1 China
- 2.5.2 India
- 2.5.3 Japan
2.6 AUSTRALASIA
- 2.6.1 Australia
- 2.6.2 New Zealand

CHAPTER 3 LEGISLATION

3.1 Europe
- 3.1.1 EMEA
- 3.1.2 France
- 3.1.3 Germany
- 3.1.4 The Netherlands
- 3.1.5 Spain
- 3.1.6 United Kingdom
3.2 North America
- 3.2.1 Canada
- 3.2.2 United States
  - Pesticides
3.3 Australasia
- 3.3.1 Australia
- 3.3.2 New Zealand

CHAPTER 4 OTC ACTIVES

4.1 Overview
4.2 Ectoparasiticides
- 4.2.1 Pyrethroids
- 4.2.2 Organophosphorus compounds
- 4.2.3 Carbamates and amidines
- 4.2.4 Insect growth regulators
- 4.2.5 Neonicotinoids
- 4.2.6 Fipronil, selamectin and ivermectin
- 4.2.7 Others (repellents)
4.3 Endoparasiticides

CHAPTER 5 CASE STUDIES

5.1 OTC spot-on ectoparasiticides
- historical perspective
- lessons to be learnt
5.2 OTC endoparasiticides
- historical perspective
- lessons to be learnt

CHAPTER 6 COMPANY PROFILES

6.1 Alfamed S.A.S.
6.2 Armitages Pet Products Limited
- 6.2.1 Flea products
- 6.2.2 Wormers
- 6.2.3 Other animal health products
6.3 Battle, Hayward & Bower Ltd
6.4 Bayer Animal Health
6.5 Beaphar Nederland B.V.
6.6 Bio-Tech Solutions Ltd
6.7 Bob Martin (UK) Ltd
6.8 Central Garden & Pet Company
6.9 Chanelle Animal Health Ltd.,
6.10 Denes Natural Pet Care Ltd.
6.11 Dorwest Herbs Ltd
6.12 The Hartz Mountain Corporation
6.13 Intervet UK
6.14 Janssen Animal Health
6.15 Johnson' s Veterinary Products Ltd
- Dog and cat products
- Small animal products (for rabbits, guinea pigs, gerbils, hamsters, etc.)
- Cage bird products
- Pigeon products
6.16 Masterfoods (Complementary Petcare)
6.17 Merial
6.18 Novartis Animal Health I nc.
6.19 Petco Animal Supplies
6.20 Pets at Home
6.21 PetSmart
6.22 Schering -Ploug h Anim al Health
6.23 Sergeant' s Pet Care Products
- Grocery/mass merchant ranges
- Specialist pet store ranges
6.24 Seven Seas Pet and Anim al Heath Care
- Seven Seas Overseas Distributors
6.25 Sinclair Anim al & Household Care
6.26 Virbac S.A.

LIST OF TABLES

Table 2.1 World animal health market by year
Table 2.2 World animal health market by region
Table 2.3 World animal health market by species
Table 2.4 World animal health market by category
Table 2.5 French animal health market by species
Table 2.6 French animal health market by category
Table 2.7 Pet animal populations in France
Table 2.8 German animal health market by category
Table 2.9 German pet food market
Table 2.10 German pet care product market
Table 2.11 German pet population
Table 2.12 Spanish animal health market by category
Table 2.13 Spanish pet food market
Table 2.14 Spanish animal health market by species
Table 2.15 Spanish animal health market by region
Table 2.16 UK sales of pet food and pet care products
Table 2.17 UK animal medicine sales by species
Table 2.18 Dog and cat populations in Scandinavian countries
Table 2.19 Brazilian animal medicine sales by category
Table 2.20 Brazilian animal market by species
Table 2.21 Japanese pet food market by species
Table 2.22 Japanese animal health market
Table 2.23 Australian pet care market
Table 2.24 Australian animal health market
Table 2.25 Australian parasiticide market
Table 6.1 Alfamed S.A.S. OTC Products authorized (AVM-GSL) in the UK
Table 6.2 Armitage Bros. OTC Products authorized (AVM-GSL) in the UK
Table 6.3 Battle, Haywood & Bower UK authorizations (AVM-GSL)
Table 6.4 Bayer AG. Antiparasitic products authorized in the UK
Table 6.5 Com parison of the classification of Bayer actives in UK and US
Table 6.6 Beaphar OTC authorized (AVM-GSL) in the UK
Table 6.7 Bio-Tech OTC Products authorized (AVM-GSL) in the UK
Table 6.8 Bob Martin OTC Products authorized (AVM-GSL) in the UK
Table 6.9 Central Garden & Pet Company sales ($ millions)
Table 6.10 Central Garden & Pet Company Subsidiaries (pet supplies)
Table 6.11 Zodiac range of OTC authorized (AVM-GSL) in the UK
Table 6.12 Intervet pet wormers and flea collars authorized in the UK
Table 6.13 Janssen AVM-GSL authorized products in UK
Table 6.14 Johnsons Vet Products OTC authorized (AVM-GSL) in the UK
Table 6.15 Masterfoods OTC range
Table 6.16 Merial Sales Revenues ($ million)
Table 6.17 Sales of Frontline and averm ectins by quarter ($ million)
Table 6.18 Frontline range and UK classification
Table 6.19 Novartis antiparasitics for com panion animals
Table 6.20 Schering Ploug h Anim al Health AVM-GSL authorizations in UK
Table 6.21 Sergeants older OTC authorized (AVM-GSL) in the UK
Table 6.22 Seven Seas OTC authorized (AVM-GSL) in the UK
Table 6.23 Sinclair OTC Products authorized (AVM-GSL) in the UK
Table 6.24 Virbac, sales by region, 2005
Table 6.25 Virbac UK authorized (AVM-GSL) products
Table 6.26 Virbac Corporation, Revenue 2005
Table 6.27 Canovel Range of OTC Products (AVM-GSL) in the UK

LIST OF FIGURES

Figure 2.1 Number of UK households with each type of pet species
Figure 2.2 US pet populations by species
Figure 2.3 US pet care product market, 2005
Figure 2.4 Australian pet population, 2005

簡介
相關商品

使用指南產品及服務須知網站導覽

星期一到星期五 / 9:30am - 6:00pm
TEL: 02-2729-4219 (+886-2-2729-4219)
E-mail: tw-info@gii.co.jp

全球動物用OTC藥的市場機會

The OTC Animal Health Global Market Opportunity

目錄